Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades, downgrades and initiations, please see our analyst ratings page.
- BMO Capital analyst Daniel Jester initiated coverage on Navan Inc (NASDAQ:NAVN) with an Outperform rating and announced a price target of $13. Navan shares closed at $8.81 on Monday. See how other analysts view this stock.
- Roth Capital analyst Jeff Martin initiated coverage on TIC Solutions Inc (NYSE:TIC) with a Buy rating and announced a price target of $10. TIC Solutions shares closed at $7.60 on Monday. See how other analysts view this stock.
- Rodman & Renshaw analyst Michael King initiated coverage on BioXcel Therapeutics Inc (NASDAQ:BTAI) with a Buy rating and announced a price target of $17. BioXcel Therapeutics shares closed at $1.54 on Monday. See how other analysts view this stock.
- Benchmark analyst Ben Klieve initiated coverage on Ingredion Inc (NYSE:INGR) with a Buy rating and announced a price target of $130. Ingredion shares closed at $112.02 on Monday. See how other analysts view this stock.
- Cantor Fitzgerald analyst Olivia Brayer Saunders initiated coverage on Tenax Therapeutics Inc (NASDAQ:TENX) with an Overweight rating and announced a price target of $35. Tenax Therapeutics shares closed at $13.98 on Monday. See how other analysts view this stock.
Considering buying INGR stock? Here’s what analysts think:
Photo via Shutterstock
Login to comment